Humabs BioMed AG

Name: Humabs BioMed AG
Telephone: +41 91 825 63 80

Swiss Biotech Association

Member

Humabs BioMed, a subsidiary of Vir Biotechnology is a leading Swiss antibody therapeutics company that discovers and develops superior antibodies directly derived from individuals who have successfully overcome major diseases.

http://www.vir.bio
+41 91 825 63 80
info@humabs.ch
Filippo Riva

Location

Via dei Gaggini 3, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2004
Number of employees in Switzerland

20-49

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

PAREXEL International (CH) AG

Parexel is focused on the development of innovative new therapies to improve the world’s health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.
4051 Basel

Perseo pharma AG

Perseo pharma: best-in-class enzyme therapeutics Perseo pharma is a preclinical-stage biotech start-up developing best-in-class enzyme therapeutics based on an innovative proprietary nanotechnology platform.
4057 Basel

Member

Vifor Pharma Management Ltd.

Vifor Pharma Group is a global pharmaceutical company. It aims to become the leader in iron deficiency, nephrology and cardio-renal therapies. The company strives to help patients around the world with severe and chronic diseases lead better, healthier lives.
Glattbrugg

Member